Saturday, April 4, 2026
23.5 C
Bengaluru

Creat Customer

MedicinMan September 2015

[wpfilebase tag=file id=51 tpl=download-button /]

Inside this Issue

1. Leading with Purpose by K. Hariram

Pharma managers must lead their team with a clear purpose – to make work meaningful.

2. Healthcare and the Freedom of Choice by Salil Kallianpur

Patients should be free to choose their healthcare provider rather than be dependent on the government. Only then will the cost of healthcare come down and the efficiency of the system increase.

3. Patient Access Part-I: A Conceptual Overview by Pankaj Mehrotra

In a highly fragmented yet alluring healthcare market one of the ways to survive and thrive is to increase patient access.

4. How to Communicate Your Incentive Compensation Plan by Amit Jain

Once you have designed an incentive compensation plan for your salesforce, how effectively you communicate it will determine the buy-in and eventual success of the plan.

5. Effective Pre-Call Planning Using Predictive Analytics by Dr. Palakodeti Ratnakar

Analytics and mobile can make the pre-call planning process dynamic and greatly increase the ROI of a call.

6. BOOK REVIEW: ‘Targetitis: the Current Organizational Disease’ by Vivek Hattangadi

A mindless drive to set targets and measure achievement can be detrimental to the health of the field force!

7. Medical Rep or Sales Person? by Hanno Wolfram

Purely economic considerations have reduced the role of the Medical Rep from scientific partner to the Doctor to a mere salesperson. How can this be amended?

Hot this week

From Collapse to Catalyst: Orchid Pharma’s Innovation-Led Phoenix Rise and the AMR Challenge

Opening Frame: The "Silent" Pandemic Meets Strategic Grit In the...

Oracle Debacle – Midlife Reinvention is an Al Generated Orwellian Lie

A Tale of Two Truths: Severance, Up in the...

Hype and Happening: GLP-1 Growth Story – Follow the Patient, not the Primary Sales

Is Obesity (Drugs) Masking Underlying (Metabolic) Risk Factors in...

Trump’s 100% Drug Tariffs Explained: The Surprising Opportunity for India

How the 2026 U.S. tariff action on branded drugs...

Topics

Hype and Happening: GLP-1 Growth Story – Follow the Patient, not the Primary Sales

Is Obesity (Drugs) Masking Underlying (Metabolic) Risk Factors in...

Can Eli Lilly Outrun the Same-Glutide Stampede with Tirzepatide and Orforglipron?

The "aspirinization" of obesity—moving from a niche, high-cost injectable...

IPM February 2026: Market Intelligence Report

Executive Summary The Indian Pharmaceutical Market (IPM) sustained its growth...

FieldForce Is Not Your Frontline Anymore. Meet the New Force in Healthcare

When drones first appeared on battlefields, military establishments reacted...
spot_img

Related Articles

spot_imgspot_img